Search Results - "Uberfuhr, Peter"

Refine Results
  1. 1

    First Experience with de novo Calcineurin‐Inhibitor‐Free Immunosuppression Following Cardiac Transplantation by Meiser, Bruno, Reichart, Bruno, Adamidis, Ioannis, Überfuhr, Peter, Kaczmarek, Ingo

    Published in American journal of transplantation (01-04-2005)
    “…The aim of this pilot study was to investigate whether de novo calcineurin‐inhibitor‐free immunosuppression after cardiac transplantation is efficacious and…”
    Get full text
    Journal Article
  2. 2

    Coronary Dilatation After Heart Transplantation by NICKEL, Thomas, BIGDELI, Amir, KACZMAREK, Ingo, ZIEGLER, Franz Von, WILBERT-LAMPEN, Ute, LACKERMAIR, Korbinian, HORSTER, Sophia, HOSTER, Eva, UBERFUHR, Peter, SCHEIDT, Wolfgang Von, WEIS, Michael

    Published in Transplantation (27-09-2011)
    “…The angiographic incidence of coronary dilatation (CD) in the nontransplant population is approximately 0.2% to 5%. The endothelial-dependent and -independent…”
    Get full text
    Journal Article
  3. 3

    Heart–lung transplantation in patients with pulmonary atresia and ventricular septal defect by Januszewska, Katarzyna, MD, PhD, Malec, Edward, MD, PhD, Juchem, Gerd, MD, PhD, Kaczmarek, Ingo, MD, PhD, Sodian, Ralf, MD, PhD, Uberfuhr, Peter, MD, PhD, Reichart, Bruno, MD, PhD

    “…Objective Heart–lung transplantation for patients with pulmonary atresia and ventricular septal defect is challenging. The aim of the study was to present a…”
    Get full text
    Journal Article
  4. 4

    Calcineurin inhibitor withdrawal and conversion to mycophenolate mofetil and steroids in cardiac transplant recipients with chronic renal failure: a word of caution by Groetzner, Jan, Kaczmarek, Ingo, Schirmer, Johannes, Überfuhr, Peter, Gulbins, Helmut, Daebritz, Sabine, Meiser, Bruno, Reichart, Bruno

    Published in Clinical transplantation (01-09-2008)
    “…:  Background:  Chronic renal failure (CRF) is a common complication of calcineurin inhibitor (CNI)‐based immunosuppression following cardiac transplantation…”
    Get full text
    Journal Article
  5. 5

    Mediastinal pheochromocytoma with single coronary blood supply: a case report by Beiras-Fernandez, Andres, Uberfuhr, Peter, Kaczmarek, Ingo, Nikolaou, Konstantinou, Weis, Florian, Ramp, Theodor, Lamm, Peter, Kreuzer, Eckart, Reichart, Bruno

    Published in The Heart surgery forum (2007)
    “…Primary pheochromocytomas located outside the adrenal glands account for only 10% of all pheochromocytomas. Mediastinal pheochromocytomas are even rarer and…”
    Get more information
    Journal Article
  6. 6

    Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle by NÄBAUER, M, BEUCKELMANN, D. J, ÜBERFUHR, P, STEINBECK, G

    Published in Circulation (New York, N.Y.) (1996)
    “…Recordings of outward currents in human ventricular myocytes revealed the presence of a large calcium-insensitive transient outward current. This current has…”
    Get full text
    Journal Article
  7. 7

    Functional profiling of human atrial and ventricular gene expression by Barth, Andreas S, Merk, Sylvia, Arnoldi, Elisabeth, Zwermann, Ludwig, Kloos, Patrick, Gebauer, Mathias, Steinmeyer, Klaus, Bleich, Markus, Kääb, Stefan, Pfeufer, Arne, Uberfuhr, Peter, Dugas, Martin, Steinbeck, Gerhard, Nabauer, Michael

    Published in Pflügers Archiv (01-07-2005)
    “…The purpose of our investigation was to identify the transcriptional basis for ultrastructural and functional specialization of human atria and ventricles…”
    Get full text
    Journal Article
  8. 8

    Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins—reduction of circulating proinflammatory and procoagulatory markers by Wang, Ying, Blessing, Frithjof, Walli, Autar K., Überfuhr, Peter, Fraunberger, Peter, Seidel, Dietrich

    Published in Atherosclerosis (01-07-2004)
    “…In addition to hypercholesterolemia, proinflammatory and prothrombotic markers have been suggested to play an important role in atherogenesis. We examined…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation by Neurohr, Claus, Huppmann, Patrick, Zimmermann, Gregor, Leuchte, Hanno, Baumgartner, Rainer, Hatz, Rudolf, Frey, Lorenz, Uberfuhr, Peter, Bittmann, Iris, Behr, Jürgen, Reichart, Bruno

    Published in Transplant international (01-06-2009)
    “…The optimal maintenance therapy after lung transplantation remains to be established. The aim of this study was to analyse the impact of tacrolimus and…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Tacrolimus or cyclosporine: Which is the better partner for mycophenolate mofetil in heart transplant recipients? by MEISER, Bruno M, GROETZNER, Jan, REICHART, Bruno, KACZMAREK, Ingo, LANDWEHR, Peter, MÜLLER, Markus, JUNG, Sebastian, ÜBERFUHR, Peter, FRAUNBERGER, Peter, STEMPFLE, Hans-Ulrich, WEIS, Michael

    Published in Transplantation (27-08-2004)
    “…The aim of this single-center study was to investigate whether trough level adjusted mycophenolate mofetil (MMF) is more efficacious in combination with…”
    Get full text
    Journal Article
  13. 13

    Long-term outcomes after 1000 heart transplantations in six different eras of innovation in a single center by Kofler, Sieglinde, Bigdeli, Amir K, Kaczmarek, Ingo, Kellerer, Diana, Müller, Thomas, Schmoeckel, Michael, Steinbeck, Gerhard, Uberfuhr, Peter, Reichart, Bruno, Meiser, Bruno

    Published in Transplant international (01-12-2009)
    “…The objective of this study was to evaluate long-term outcomes of cardiac transplantation (HTx) in different eras of innovation at a single center during a…”
    Get more information
    Journal Article
  14. 14

    Heart transplantation: an approach to treating primary cardiac sarcoma? by Uberfuhr, Peter, Meiser, Bruno, Fuchs, Alexandra, Schulze, Costas, Reichenspurner, Hermann, Falk, Martin, Weiss, Max, Wintersperger, Bernd, Issels, Rolf, Reichart, Bruno

    “…Treating rare, primary cardiac soft-tissue sarcomas (C-STS) with heart transplantation (HTx) is controversial. Conventional tumor resection only partially…”
    Get more information
    Journal Article
  15. 15

    Assessment of cardiac allograft vasculopathy late after heart transplantation: when is coronary angiography necessary? by Störk, Stefan, Behr, Thomas M, Birk, Michael, Uberfuhr, Peter, Klauss, Volker, Spes, Christoph H, Angermann, Christiane E

    “…Cardiac allograft vasculopathy (CAV) represents a major prognostic factor in long-term survivors of heart transplantation (HTx). Reliable diagnosis of CAV late…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    A novel pulsatile bioreactor for mechanical stimulation of tissue engineered cardiac constructs by Hollweck, Trixi, Akra, Bassil, Häussler, Simon, Uberfuhr, Peter, Schmitz, Christoph, Pfeifer, Stefan, Eblenkamp, Markus, Wintermantel, Erich, Eissner, Günther

    Published in Journal of functional biomaterials (20-07-2011)
    “…After myocardial infarction, the implantation of stem cell seeded scaffolds on the ischemic zone represents a promising strategy for restoration of heart…”
    Get full text
    Journal Article
  19. 19

    Incomplete sympathic reinnervation of the orthotopically transplanted human heart: Observation up to 13 years after heart transplantation by Überfuhr, Peter, Ziegler, Sibylle, Schwaiblmair, Martin, Reichart, Bruno, Schwaiger, Markus

    “…Objective: Heart transplantation (HTx) is associated with autonomic denervation of the donor heart. Sympathetic reinnervation (RI) as defined by the presence…”
    Get full text
    Journal Article
  20. 20

    Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates by Köhler, M, Hellstern, P, Lechler, E, Uberfuhr, P, Müller-Berghaus, G

    Published in Thrombosis and haemostasis (01-09-1998)
    “…In 1994, shortly after a heat-treated prothrombin complex concentrate (PCC) had been withdrawn from the German market due to transmission of hepatitis B, the…”
    Get more information
    Journal Article